Physician
Nephrology
Dr. Venkat R. Peddi, MD
|
|
Give Review
Dr. Venkat R. Peddi works in the field of Nephrology. He went to medical school at University Hospital - University of Cincinnati College of Medicine. He received awards:"Fellow (ASNF)". Venkat Peddi is also published. He has 44 publications published. The lastest publication: "A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus.' Venkat Peddi accepts all Medicare patients.
Publications
- Review of combination therapy With mTOR inhibitors and tacrolimus minimization after transplantation.
- Altered balance between effector T cells and FOXP3(+) HELIOS(+) regulatory T cells after thymoglobulin induction in Kidney transplant recipients.
- Early corticosteroid withdrawal in the real world: A long-term analysis of Kidney transplant recipients from the Mycophenolic Acid Observational Renal Transplant Regis...
- Control of risk factors for cardiovascular Disease in long-term renal transplant recipients.
- HLA-identical Renal transplant recipients: immunosuppression, long-term complications, and survival.
- Recent advances in immunosuppressive therapy for Renal transplantation.
- Immediate allograft dysfunction due to atheroembolic Disease.
- A blinded retrospective analysis of Renal allograft pathology using the Banff schema: implications for clinical management.
- Recurrent and de novo glomerular Disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR).
- Graft outcome in patients with biopsy-proven Chronic renal allograft rejection.
- Long-term outcome in simultaneous Kidney and pancreas transplant recipients with functioning allografts at 1-year posttransplantation.
- Nine-month follow-up of SangCya (Sang-35) in Kidney transplant patients after conversion from Sandimmune.
- Recurrent and de novo glomerular Disease after renal transplantation: a report from renal allograft Disease registry.
- A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus.
- Tacrolimus use in kidney-pancreas recipients is associated with less Acute renal dysfunction than cyclosporine.
- Conversion of stable Renal transplant recipients from Sandimmune to Sang-35, a Neoral-equivalent cyclosporine formulation, using a dose-adjusted method.
- Use of tacrolimus eliminates Acute rejection as a major complication following simultaneous kidney and pancreas transplantation.
- Malignancies complicating organ transplantation.
- Characteristics of long-term Renal transplant survivors.
- Long-term Kidney and pancreas function with tacrolimus immunosuppression following simultaneous Kidney and pancreas transplantation.
- Primary therapy with OKT3 for biopsy-proven Acute renal allograft rejection.
- Recurrent and de novo renal Diseases after renal transplantation: a report from the renal allograft disease registry.
- Tacrolimus eliminates Acute rejection as a major complication following simultaneous kidney and pancreas transplantation.
- Efficacy of OKT3 as primary therapy for histologically confirmed Acute renal allograft rejection in simultaneous kidney and pancreas transplant recipients.
- Efficacy of OKT3 as primary therapy for histologically confirmed Acute renal allograft rejection.
- Causes of Renal allograft loss in black vs. white transplant recipients in the cyclosporine era.
- Primary care of patients With renal transplants.
- Long-term renal and pancreas function with tacrolimus rescue therapy following Kidney/pancreas transplantation.
- Efficacy and safety of tacrolimus versus cyclosporine in Kidney and pancreas transplant recipients.
- Proteinuria following renal transplantation: correlation With histopathology and outcome.
- Disseminated histoplasmosis in Renal allograft recipients.
- Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in Renal allograft recipients.
- Impact of ganciclovir prophylaxis on cytomegalovirus infection in cadaveric Kidney vs combined Kidney and pancreas transplantation.
- Catastrophic secondary antiphospholipid syndrome With concomitant antithrombin III deficiency.
- Polyomavirus in Kidney and Kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring.
- MALToma: a Helicobacter pylori-associated malignancy in transplant patients: a report from the Israel Penn International Transplant Tumor Registry With a review of pub...
- Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo Kidney allograft recipients.
- Alemtuzumab induction in Renal transplantation.
- A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor Kidney transplantation.
- An open-label, pilot study evaluating the safety and efficacy of converting from calcineurin inhibitors to sirolimus in established renal allograft recipients With mod...
- Laparoscopic donor nephrectomy vs. open live donor nephrectomy: a quality of life and functional study.
- Incidental diagnosis of gastric cancer in transplant recipients improves patient survival.
- Safety, efficacy, and cost analysis of thymoglobulin induction therapy with intermittent dosing based on CD3+ lymphocyte counts in Kidney and Kidney-pancreas transplan...
Schools
Gandhi Medical College Ntr
Gandhi Hospital
Rochford Hospital
Southend Hospital
Univ Of Cincinnati HospHolmes Div
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Chronic Glomerulonephritis
- Chronic Kidney Diseases
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Fellow (ASNF)
Education
-
University Hospital - University of Cincinnati College of Medicine -
Gandhi Medical College
Drug Facts
| NPI NUMBER | 1417974247 | |
| NPPES Provider LastName | PEDDI | |
| NPPES Provider FirstName | VENKAT | |
| NPPES Provider ZIPCode | 941151932 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 2409.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 21.0 | |
| Percent Opioid Claims | 0.87 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1417974247 |
| Last Name Of The Provider | PEDDI |
| First Name Of The Provider | VENKAT |
| View All |
Similar Doctors
|
|
Dr. Darryl L. Raszl, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence L. Bohannon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael F. Borah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Lovett, MD |
|
|
Dr. Puneet Sood, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael W. Weiner, MD |
|
|
Dr. Maian N. Ye, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter A. Lee, MD |
|
|
Dr. Manjula Kurella, MD
This Doctor is OpenDoctor Recommended.
|